| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eddf4408975428fb744d445d3f029853 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4748
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-16 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4748
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485 |
| filingDate |
2000-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c75c2e48f0cb8f849ae263b99186c9c6 |
| publicationDate |
2000-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0072835-A2 |
| titleOfInvention |
Topical application of muscarinic and opioid agents for treatment of tinnitus |
| abstract |
The present invention relates to a composition and methods for treating tinnitus. In preferred embodiments of the invention, muscurinic and/or opioid agents are administered to the affected ear in amount effective to relieve one or more tinnitus symptoms. A preferred agent is an anticholinesterase inhibitor, such as neoostigmine. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0115678-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0224176-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0115678-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1190709-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020163588-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1559420-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0224176-A3 |
| priorityDate |
1999-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |